PMV Pharmaceuticals, Inc. - COM (PMVP)

Historical Portfolio Holders from Q3 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
39M
Holdings value Q3 2024
$58.2M
Value change Q3 2024
-$2.42M
Grand Portfolio weight change Q3 2024
0%
Number of holders
73
Number of buys Q3 2024
0
Number of sells Q3 2024
0
Average buys Q3 2024 %
0
Average sells Q3 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 39M $58.2M -$2.42M $1.49 73
2024 Q2 40.5M $65.6M -$3.76M $1.62 90
2024 Q1 42.7M $72.6M -$11.8M $1.70 95
2023 Q4 46.5M $144M -$52.2M $3.10 98
2023 Q3 54.2M $333M +$15.4M $6.14 104
2023 Q2 51.7M $324M +$3.28M $6.26 104
2023 Q1 51.5M $246M -$16.2M $4.77 111
2022 Q4 54.5M $474M -$38.3M $8.70 112
2022 Q3 58.2M $692M -$36.6M $11.90 116
2022 Q2 61.1M $871M +$53.5M $14.25 108
2022 Q1 55.2M $1.15B +$162M $20.82 104
2021 Q4 47.5M $1.1B +$15.2M $23.10 103
2021 Q3 44M $1.31B +$46.8M $29.80 91
2021 Q2 42.2M $1.44B +$80M $34.16 85
2021 Q1 39.9M $1.31B +$51.9M $32.89 81
2020 Q4 38.2M $2.34B +$185M $61.51 72
2020 Q3 31.2M $1.1B +$1.1B $35.50 51